Eurofins Genomics Sequencing: Fast & Reliable Results
In the world of DNA sequencing, Eurofins Genomics stands out as a beacon of excellence. With nearly four decades of experience, this powerhouse in genetic analysis has been pushing the boundaries of genomics services1. Their commitment to speed and accuracy is unparalleled, offering overnight results nationwide and boasting a stunning 99.999% accuracy rate in Sanger Sequencing23.
What sets Eurofins apart is not just their speed, but their comprehensive approach to genomics services. From Sanger Sequencing to cutting-edge Nanopore technology, they cover the full spectrum of DNA sequencing needs1. This versatility makes them a go-to choice for researchers, clinicians, and industry professionals alike.
Eurofins’ impact spans across various sectors. They’ve been instrumental in developing new drugs and vaccines, optimizing crop health, and enhancing biologics in the pharmaceutical industry1. Their client roster reads like a who’s who of scientific excellence, including renowned scientists and lab managers who trust Eurofins with their critical research.
Cost-effectiveness is another feather in Eurofins’ cap. With free shipping for over 90% of orders and competitive pricing, they make top-tier genetic analysis accessible to a wide range of researchers3. This commitment to affordability doesn’t come at the cost of quality – Eurofins consistently outperforms competitors in annual benchmark comparisons2.
Key Takeaways
- Eurofins offers 99.999% accuracy in Sanger Sequencing
- Nationwide overnight results available, even on Saturdays
- Free shipping for most orders, saving $20-$34 compared to others
- Versatile services including Sanger, Nanopore, and Gene Synthesis
- Supports various industries from clinical to agroscience
- Consistently outperforms competitors in quality benchmarks
- Flexible prepaid sequencing options for researchers
Introduction to Eurofins Genomics Sequencing
Eurofins Genomics offers cutting-edge DNA sequencing technology for genomic analysis and genetic research. Their services cater to diverse needs in the field of genetics, providing reliable and fast results.
Overview of Sequencing Services
Eurofins Genomics provides a range of sequencing options to meet various research requirements. They offer two main types of whole-genome sequencing: de novo sequencing for first-time genome investigations and whole-genome re-sequencing when a reference genome is available4. Their INVIEW Resequencing product is designed for comparative analysis, while the INVIEW Human Exome caters to specific genomic research needs4.
For more targeted approaches, Eurofins offers services like ShortSeq plate sequencing, which typically handles read lengths below 550 bases and provides results by 9 am the next day5. They also offer Ready2Load services for samples with read lengths between 500-700 base pairs, providing flexibility for different project requirements5.
Importance of Reliable Genetic Data
Reliable genetic data is crucial for advancing genomic research and applications. Eurofins ensures data quality through various measures:
- Secure online archive of sequence data for 6 months5
- Over 80 standard vector primers offered at no cost5
- Technical support available Monday to Friday5
These features contribute to the accuracy and reliability of genetic data, essential for applications in research, clinical diagnostics, and personalized medicine.
| Service | Features | Turnaround Time |
|---|---|---|
| ShortSeq Plate | Read lengths below 550 bases | Results by 9 am next day |
| Ready2Load | Read lengths 500-700 base pairs | Improved turnaround time |
| Standard Plates | Balance of quality and flexibility | Standard processing time |
Types of Sequencing Offered by Eurofins
Eurofins Genomics provides a range of DNA sequencing methods and genetic analysis techniques to meet diverse research needs. Their services cater to various projects, from small-scale analyses to large genomic studies6.
Sanger Sequencing
Sanger sequencing remains a popular choice for many researchers. Eurofins offers fast turnaround times, with 98% of results delivered within one business day7. This method is ideal for sequencing plasmids, PCR products, and other short DNA fragments.
Next-Generation Sequencing (NGS)
For high-throughput applications, Eurofins provides NGS services. These include de novo genome sequencing and re-sequencing projects6. NGS techniques offer rapid analysis of large genomic regions, making them suitable for complex genetic studies.
Targeted Sequencing
Eurofins also offers targeted sequencing for specific genomic regions. This approach is cost-effective for projects focusing on particular genes or genetic variations. Targeted sequencing can achieve high consensus accuracy for SNPs, reaching 99.6%7.
| Sequencing Type | Turnaround Time | Accuracy | Best For |
|---|---|---|---|
| Sanger Sequencing | 1 business day | High | Short DNA fragments |
| NGS | Varies by project | 98.3% (raw read) | Large genomic studies |
| Targeted Sequencing | Project-dependent | 99.6% for SNPs | Specific genetic regions |
Eurofins Genomics’ sequencing services cater to a wide range of projects, from small-scale analyses to complex genomic studies. Their commitment to quick turnaround times and high accuracy makes them a reliable choice for researchers across various fields67.
Applications of Eurofins Sequencing Services
Eurofins Genomics offers a wide range of sequencing services that cater to various genomic applications. Their expertise spans over three decades, making them pioneers in custom DNA synthesis and sequencing8. The company’s advanced technologies support cutting-edge genetic research and clinical genomics, driving progress in healthcare R&D, agriculture, and genealogy8.
Research and Development
In the realm of research and development, Eurofins has been a trusted partner for academic researchers for over 35 years1. Their sequencing services play a crucial role in experimental science, helping scientists unravel genetic mysteries and advance knowledge in life sciences. The company’s oligonucleotides are vital tools in detecting and treating infectious diseases1.
Clinical Diagnostics
Eurofins Genomics’ sequencing services are integral to clinical diagnostics. Their products aid in identifying sequence variations and modifications, crucial for improving the design and production of biologics1. The company’s commitment to quality is evident in their adherence to GMP, GLP, and ISO standards, ensuring reliable results for clinical applications1.
Personalized Medicine
The field of personalized medicine has greatly benefited from whole genome sequencing. Eurofins Genomics’ sequencing services support this growing trend by providing high-fidelity, customizable oligonucleotide synthesis for Next Generation Sequencing (NGS) requirements8. This technology enables healthcare professionals to tailor treatments based on individual genetic profiles.
| Application | Key Benefit | Eurofins Advantage |
|---|---|---|
| Research and Development | Advancing experimental science | 35+ years of academic research support |
| Clinical Diagnostics | Improving biologics design | GMP, GLP, ISO compliant facilities |
| Personalized Medicine | Tailored genetic insights | Customizable NGS-ready oligo synthesis |
As NGS technologies become more affordable and versatile, Eurofins Genomics continues to adapt its services to meet evolving needs in genomic applications, fostering advancements towards a healthier future8.
Quality Assurance in Sequencing
Eurofins Genomics stands at the forefront of sequencing accuracy and genomic data reliability. Their commitment to quality control is evident in their pioneering efforts and cutting-edge technologies.
Commitment to Accuracy
Eurofins Genomics US operates as an accredited GMP laboratory, adhering to the highest quality standards. They meet or exceed FDA guidelines for GLP regulations and hold additional quality certifications in ISO 9001 and ISO 134859. This dedication ensures top-notch sequencing accuracy and genomic data reliability.
The company’s GLP certified sequencing service includes validated procedures, equipment calibration, ongoing staff training, and restricted lab access. These measures result in impressive final sequencing data accuracy guarantees: 2-fold coverage exceeds 99.999% accuracy, while 4-fold coverage surpasses 99.99999%9.
Advanced Technology Utilization
Eurofins Genomics employs state-of-the-art technologies for quality control. They pioneered 100% MS testing of oligonucleotides in 1998 and use electrospray ionization Mass Spectrometry for every oligo10. This advanced approach ensures superior sequencing accuracy.
For enhanced quality control, they offer various analytical options:
- HPLC for verifying oligo purity
- Capillary electrophoresis for measuring truncated versus full-length products
- Custom quality control options for commercial scale projects10
Eurofins Genomics’ commitment to quality extends beyond technology. They provide comprehensive support, including technical assistance and billing services, to ensure smooth operations and customer satisfaction10. This holistic approach to quality assurance sets new standards in genomic data reliability.
| Quality Measure | Description | Impact on Reliability |
|---|---|---|
| GMP Accreditation | Laboratory #3009882691 | Ensures highest quality standards |
| GLP Certification | Meets FDA guidelines | Guarantees regulatory compliance |
| ISO Certifications | ISO 9001 and ISO 13485 | Demonstrates quality management excellence |
| Sequencing Accuracy | Up to 99.99999% (4-fold coverage) | Provides highly reliable genomic data |
Eurofins Sequencing Workflow
Eurofins Genomics offers a streamlined sequencing protocol for various genomic projects. Their workflow combines cutting-edge technology with expert knowledge to deliver accurate results.
Sample Preparation Process
The first step in the sequencing workflow is sample preparation. Eurofins Genomics uses advanced techniques to ensure high-quality DNA samples. They offer direct colony sequencing using rolling circle amplification for bacterial and fungal samples, providing top-notch genomic information11.
Sequencing Execution Steps
Eurofins employs both Sanger sequencing and Next-Generation Sequencing (NGS) methods. Sanger sequencing uses fluorescently labeled ddNTPs, while NGS is preferred for large-scale projects. The choice between these methods depends on the specific project needs and sample characteristics12.
| Sequencing Method | Best For | Key Feature |
|---|---|---|
| Sanger Sequencing | Single genes, Cost-efficient single samples | Uses fluorescent ddNTPs |
| NGS | 100+ genes, Whole genomes, Low DNA input | High-throughput capabilities |
Data Analysis Methods
After sequencing, Eurofins applies robust bioinformatics tools for genomic data processing. Their analysis includes SNP/InDel detection and genotyping. The use of customized oligonucleotides, ranging from 15 to 30 bases, enhances the accuracy of sequencing and subsequent data analysis13.
Eurofins Genomics maintains strict quality control measures throughout the sequencing process, ensuring reliable and accurate results for research, clinical diagnostics, and personalized medicine applications11.
Turnaround Times for Sequencing
Eurofins Genomics stands out in the field of rapid sequencing, offering impressive turnaround times for various genetic analysis needs. Their commitment to quick genetic results has made them a leader in DNA analysis speed.
Fast Turnaround Options
For those needing swift results, Eurofins Genomics delivers single DNA reads in just 25-30 hours14. This rapid sequencing service caters to urgent research and clinical needs. The company’s whole plasmid sequencing typically takes only one business day from sample receipt, with 95% of results delivered within this timeframe7.
Standard Sequencing Timelines
While speed is a key focus, Eurofins Genomics balances rapid turnaround with high-quality results. Their total annual sequencing capacity reaches about 2 million reads, supported by three production sites in Germany, the US, and India14. This extensive capacity ensures they can handle both fast-track and standard projects efficiently.
Pricing for sequencing services varies based on sample type, ranging from $15 to $105 per sample7. Eurofins Genomics uses advanced technology to maintain accuracy, with Oxford Nanopore reporting 98.3% raw read accuracy and 99.6% consensus accuracy for SNPs at 50X coverage7.
The company’s ecom platform streamlines the ordering process, allowing customers to track orders and access bioinformatics tools for designing primers, probes, and siRNA14. This user-friendly system, combined with their rapid sequencing capabilities, makes Eurofins Genomics a top choice for researchers and clinicians seeking fast, reliable genetic analysis.
Customer Support and Consultation Services
Eurofins Genomics takes pride in its world-class genomics customer service, offering comprehensive support throughout your sequencing journey. From project planning to data interpretation, their team of expert scientists is ready to assist you every step of the way15.
Pre-Sequencing Consultation
Before you begin your sequencing project, Eurofins provides valuable pre-sequencing consultation. Their specialists help you optimize your experimental design, select the most suitable sequencing method, and ensure proper sample preparation. This service is available for projects ranging from single sample analysis to high-throughput studies involving thousands of samples16.
Post-Sequencing Support
Eurofins’ sequencing project support extends beyond data generation. Their team offers assistance in interpreting results, troubleshooting issues, and applying findings to your research or clinical needs. With expertise in various genetic analysis methods, they can guide you through complex data sets and help unlock valuable insights16.
Customer service representatives are accessible via phone and email during extended business hours. Technical support is available Monday through Thursday from 8:00 AM to 6:00 PM and on Friday from 8:00 AM to 6:00 PM, ET16.
Eurofins Genomics maintains high quality standards, holding certifications for ISO 9001, ISO 13485, and ISO 17025. This commitment to excellence ensures reliable and accurate sequencing results for your projects16.
Whether you’re conducting preclinical research or clinical trials, Eurofins’ customer support team is equipped to provide tailored guidance. They can assist in designing sampling plans, selecting appropriate sites, and implementing corrective actions when needed17.
Pricing Structure for Sequencing Services
Eurofins Genomics offers competitive pricing for DNA analysis. Their affordable sequencing options cater to various needs and budgets. Let’s explore the pricing models and discounts available.
Competitive Pricing Models
Eurofins provides a range of genomics pricing options. Manual DNA extraction costs between $14 and $21 for internal users, while automated extraction starts at $6 for large batches18. For genome library preparation, prices begin at $65 per sample for internal users18. These rates ensure accessible DNA analysis costs for researchers and institutions.
Volume Discounts and Offers
Eurofins rewards bulk orders with attractive discounts. RNA library preparation costs decrease as sample numbers increase, with prices starting at $75 per sample for external users ordering more than 48 samples18. The company also offers various sequencing options, such as Illumina iSeq at $790 for internal users and Illumina NextSeq ranging from $1,070 to $3,770 based on read length and user category18.
| Service | Internal User Price | External User Price |
|---|---|---|
| Manual DNA Extraction | $14 – $21 | Varies |
| Automated DNA Extraction (96+ samples) | $6 | Varies |
| Genome Library Preparation | $65 | Up to $100 |
| Illumina iSeq Sequencing | $790 | $890 |
Eurofins’ gene order platform streamlines the process by allowing multiple gene orders at once and offering express services for urgent needs19. They provide technical support on weekdays from 8:00 AM to 6:00 PM, ensuring customers get the help they need with their sequencing projects19.
Case Studies: Successful Sequencing Projects
Eurofins Genomics has made significant strides in genomics research and sequencing applications, contributing to groundbreaking genetic discoveries. Their advanced technologies have revolutionized various fields, from medical diagnostics to environmental studies.
Research Breakthroughs
A recent study utilizing long-read sequencing technology analyzed 22 patients with neurological and neuromuscular diseases. The method successfully captured 59 targeted loci with a mean coverage depth of 24.7 for all patients, accurately identifying repeat expansions in 12 positive controls20. This breakthrough demonstrates the power of sequencing in unraveling complex genetic disorders.
In another project, RAD-tag sequencing provided short sequences flanking restriction enzyme cut sites, yielding thousands of loci distributed throughout the genome. This method helped fine-tune interpretations of classical mitochondrial markers used in octocoral species delimitation, uncovering previously undetected diversity21.
Clinical Success Stories
Eurofins Genomics’ SARS-CoV-2 Genome Sequencing package has been instrumental in COVID-19 research. The service guarantees 5 million read pairs per package, with over 80% of base calls achieving a quality value higher than Q3022. This high accuracy has been crucial for tracking viral mutations and developing targeted treatments.
The INVIEW Human Exome Advance service has also shown remarkable results in clinical settings. It covers approximately 60 Mbp of exonic bases, with more than 93% of targets covered with >20x and 90% of genes completely covered22. This comprehensive coverage has led to faster and more accurate diagnoses of genetic disorders.
| Sequencing Service | Key Feature | Impact |
|---|---|---|
| Long-read Sequencing | Mean coverage depth of 24.7 | Accurate identification of repeat expansions |
| RAD-tag Sequencing | Thousands of loci across genome | Uncovered hidden species diversity |
| SARS-CoV-2 Genome Sequencing | >80% base calls with Q30 quality | Crucial for tracking viral mutations |
| INVIEW Human Exome Advance | >93% targets covered with >20x | Faster, more accurate genetic diagnoses |
These case studies highlight the transformative impact of Eurofins Genomics’ sequencing services across various scientific disciplines, paving the way for future advancements in genomics research and clinical applications.
Eurofins in Comparison to Competitors
In the genomics service comparison landscape, Eurofins Genomics stands out among DNA sequencing providers. The company offers a unique blend of speed, accuracy, and innovation that sets it apart from competitors.
Unique Features of Eurofins Sequencing
Eurofins Genomics delivers exceptional accuracy in its sequencing services. Their Sanger sequencing boasts a 99.99% accuracy rate, while their new low-cost whole plasmid sequencing service achieves up to 99% single-base accuracy2323. This level of precision is crucial for research and clinical applications alike.
Speed is another hallmark of Eurofins’ service. The company’s strategic location near the UPS hub for North America enables same-day results for samples received, a feature unmatched by many competitors23. This rapid turnaround time is particularly valuable for time-sensitive projects.
How Eurofins Stands Out
Eurofins Genomics distinguishes itself through its advanced technology and versatility. The company’s NovaSeq6000 platform allows DNA sequencing five times faster than previous methods, at a lower cost per base24. This capability positions Eurofins as a leader in both speed and cost-effectiveness.
The range of applications Eurofins serves is impressive. From microbiome analysis for disease identification to exome sequencing for cancer research, Eurofins caters to diverse needs across pharma, biotech, agriculture, and academia24. This versatility makes Eurofins a one-stop shop for various sequencing requirements.
| Feature | Eurofins Genomics | Typical Competitors |
|---|---|---|
| Sanger Sequencing Accuracy | 99.99% | Up to 99% |
| Whole Plasmid Sequencing | 2.5 to 300 kb | Limited range |
| Turnaround Time | Same-day results possible | Often several days |
| NGS Technology | NovaSeq6000 (5x faster) | Varied, often older tech |
With its combination of accuracy, speed, and diverse applications, Eurofins Genomics proves to be a formidable competitor in the DNA sequencing market. As genomics continues to advance, Eurofins’ commitment to innovation positions it at the forefront of the field.
Recent Innovations in Sequencing Technology
Eurofins Genomics leads the charge in genomic technology advancements, constantly updating its sequencing platforms. The company has made significant strides in expanding its capabilities and service offerings to meet the evolving needs of researchers and clinicians25.
Updates to NGS Platforms
A major breakthrough in sequencing innovations is the introduction of Nanopore technology. This cutting-edge platform allows for real-time sequencing of whole DNA or RNA molecules, with the ability to read sequences exceeding 2 million bases in length26. Eurofins Genomics has embraced this technology, launching AAV sequencing and expanding its service portfolio to include bacterial genome and amplicon sequencing using the Oxford Nanopore (ONT) platform25.
The MinION device, a portable and cost-effective Nanopore sequencer, has revolutionized field genomics. Its hand-held design enables on-site sequencing, crucial for rapid response in disease outbreaks or immediate clinical diagnoses26.
Advancements in Data Processing
Eurofins Genomics has made remarkable progress in data processing, offering same-day results for low-cost whole plasmid sequencing25. This speed is possible due to Nanopore technology’s ability to provide instantaneous data during sequencing reactions26.
The company’s advancements extend beyond speed. Nanopore sequencing’s error correction mechanisms gradually improve the accuracy of long-read sequences, enhancing overall data quality26. These improvements in data processing and analysis have significantly boosted the efficiency and reliability of genomic research and clinical applications2526.
Understanding Sequencing Data
Deciphering sequencing data is crucial for effective genomic data analysis. Eurofins Genomics offers comprehensive support in this area, providing various file formats and tools to aid in DNA sequence interpretation.
Data Formats Provided
Eurofins Genomics delivers sequencing results in five distinct file types: AB1, SCF, PDF, PHRED, and SEQ27. These formats cater to different analysis needs and software compatibility. For viewing trace or chromatogram files, researchers can choose from free tools like GeneStudio Pro, Chromaseq, and UGENE, or opt for paid software such as Chromas Pro and CodonCode Aligner for more advanced features27.
Interpreting Sequencing Results
Successful DNA sequence interpretation relies on understanding the quality of the data. A well-formed sequence typically shows a 77% success rate with clear, separated peaks and good quality scores28. However, challenges may arise, such as noisy backgrounds or mid-sequence stops, often due to factors like clone contamination or secondary structures in DNA templates28.
To ensure accurate genomic data analysis, Eurofins Genomics maintains high standards. Their Sanger Sequencing boasts 99.999% accuracy with a 97.3% success rate across all applications2. This level of precision is crucial for researchers relying on sequencing data for critical studies and clinical applications.
| File Type | Purpose | Compatible Software |
|---|---|---|
| AB1 | Raw data | Chromas, SnapGene |
| SCF | Standard chromatogram | 4Peaks, UGENE |
| Visual representation | Any PDF viewer | |
| PHRED | Quality scores | Specialized analysis tools |
| SEQ | Sequence text | Text editors, BLAST |
By providing diverse file formats and supporting various analysis tools, Eurofins Genomics empowers researchers to conduct thorough genomic data analysis and precise DNA sequence interpretation, advancing scientific discovery and clinical applications.
The Role of Bioinformatics in Sequencing
Bioinformatics plays a crucial role in modern sequencing processes. Eurofins Genomics leverages its expertise to provide cutting-edge bioinformatics services and genomic data management solutions. With over 6 years of experience in NGS services, the company has developed a robust set of tools and techniques for handling complex genomic data29.
Overview of Bioinformatics Tools
Eurofins Genomics offers a comprehensive suite of bioinformatics tools designed to analyze and interpret sequencing data. These tools support a wide range of applications, from basic sequence analysis to complex genomic studies. The company’s multiplatform approach to Next-generation sequencing (NGS) ensures that customers have access to various options tailored to their specific research needs30.
Data Management Techniques
Efficient genomic data management is critical for handling large-scale sequencing projects. Eurofins Genomics combines knowledge from various fields, including oligonucleotide synthesis, DNA sequencing, and applied genetics, to develop effective data management strategies29. Their expertise extends to specialized areas such as exome sequencing, transcriptome studies, and microbiome profiling30.
| Bioinformatics Service | Application | Benefit |
|---|---|---|
| NGS Data Analysis | Genomic and cDNA libraries | Comprehensive sequence interpretation |
| Sanger Sequencing Analysis | PCR product sequencing | Fast turnaround and high flexibility |
| Epigenetic Analysis | DNA methylation studies | Insights into gene regulation |
Eurofins Genomics’ bioinformatics capabilities are backed by years of experience and a dedicated team of experts. For specialized support or inquiries about their bioinformatics services and genomic data management solutions, customers can reach out to their technical support team or use their online quoting tool for project-specific requests29.
Future Trends in Sequencing Technology
The future of genomics is rapidly evolving, with sequencing technology trends shaping the landscape of healthcare and research. As we look ahead, the impact of these advancements promises to revolutionize personalized medicine and genetic diagnostics.
Predictions for Genetic Sequencing
Genetic sequencing is poised for significant growth. The Next Generation Sequencing Technology Market is expected to grow at a 5.5% CAGR from 2024 to 2031, driven by innovations in targeted, whole exome, and whole genome sequencing31. This growth reflects the increasing demand for precision medicine and advanced diagnostic tools.
Key players like Eurofins Scientific, Illumina, and Roche are at the forefront of these advancements, pushing the boundaries of what’s possible in DNA sequencing31. Their ongoing investments in new technologies are likely to yield faster, more accurate, and cost-effective sequencing methods in the coming years.
Impact on Healthcare and Research
The impact of sequencing advancements on healthcare is profound. Rare diseases, affecting 1 in 17 people globally, stand to benefit greatly from improved genetic diagnostics32. In research, next-generation sequencing is revolutionizing clinical microbiology, enabling precise identification of bacterial and fungal species33.
Genomic applications in cancer treatment are a major driver for DNA sequencing market growth32. This trend is expected to continue, with sequencing playing an increasingly crucial role in developing targeted therapies and personalized treatment plans.
| Application Area | Current Impact | Future Potential |
|---|---|---|
| Rare Disease Diagnosis | Affecting 475 million globally | Improved early detection and treatment |
| Cancer Treatment | Driving DNA sequencing market | Highly personalized therapy options |
| Microbiology | Precise pathogen identification | Rapid outbreak tracking and control |
As sequencing technologies continue to advance, we can expect breakthroughs in understanding complex genetic disorders, developing new drugs, and creating more targeted therapeutic approaches. The future of genomics holds promise for transforming healthcare and pushing the boundaries of scientific research.
Conclusion: Why Choose Eurofins Genomics Sequencing
Eurofins Genomics stands out as a top-tier genomics partner, offering reliable sequencing services that cater to diverse research needs. With a swift turnaround time of 6-8 weeks for complex projects like Eukaryotic and Bacterial/Fungal Genome Sequencing, Eurofins proves its efficiency in delivering results34.
Summary of Advantages
The company’s expertise shines through its state-of-the-art sequencing platforms, including Illumina NextSeq500, HiSeq 2500, and NovaSeq. These technologies enable Eurofins to handle a wide range of genome sequencing projects with precision34. Their commitment to quality is evident in their meticulous sample requirements and library preparation methods, ensuring optimal results for each project.
Encouragement to Get Started
Eurofins Genomics’ impact spans various fields, from investigating the gut microbiome in psoriasis patients to advancing ovarian cancer detection through cell-free DNA methylation analysis35. Their contributions to SARS-CoV-2 research and studies on microbial community diversity showcase their versatility as a reliable genomics partner35. By choosing Eurofins, you’re not just selecting a service provider; you’re partnering with a leader in genomic innovation, ready to support your research journey with cutting-edge technology and expert guidance.
Q&A
What types of sequencing services does Eurofins Genomics offer?
Eurofins Genomics offers a wide range of sequencing services, including Sanger Sequencing, Next-Generation Sequencing (NGS), and targeted sequencing. Sanger Sequencing is considered the gold standard with 99.999% accuracy, while NGS is used for high-throughput applications. Targeted sequencing focuses on specific genomic regions.
How accurate is Eurofins Genomics’ sequencing?
Eurofins Genomics maintains high-quality standards with a 99.999% accuracy rate for Sanger Sequencing. They consistently outperform other vendors on quality metrics such as read length and Q20 score, as demonstrated in annual benchmark comparisons.
What is the turnaround time for sequencing results?
Eurofins Genomics offers nationwide overnight sequencing results throughout the continental US. Samples submitted using their digital shipping labels typically receive results by 10 AM the next day, even on Saturdays. Standard sequencing timelines are also available for larger projects or those requiring additional services.
What applications does Eurofins Genomics’ sequencing support?
Eurofins Genomics sequencing services support various applications, including research and development in life sciences, clinical diagnostics for disease identification, and personalized medicine approaches. They also offer GLP and GMP sequencing for preclinical and regulated studies.
Does Eurofins Genomics provide customer support for sequencing projects?
Yes, Eurofins Genomics provides comprehensive customer support, including pre-sequencing consultation to help with project planning and sample preparation. They also offer post-sequencing support to assist with data interpretation and troubleshooting. Customer service representatives are available via phone and email during extended business hours.
How does Eurofins Genomics’ pricing compare to competitors?
Eurofins Genomics offers competitive pricing for their sequencing services. They provide various prepaid sequencing options, including SimpleSeq, Prepaid Plates, and FlexReads, which are convenient and grant-friendly. Volume discounts are available for larger projects, and they offer free shipping on over 90% of orders through digital shipping labels.
What bioinformatics capabilities does Eurofins Genomics offer?
Eurofins Genomics integrates advanced bioinformatics tools into their sequencing services for comprehensive data analysis. They offer data management techniques to handle large-scale genomic information efficiently. Their bioinformatics capabilities support various applications, from basic sequence analysis to complex genomic studies.
How does Eurofins Genomics ensure the quality of their sequencing results?
Eurofins Genomics utilizes advanced technologies and stringent quality control measures to ensure reliable and reproducible results. They have a streamlined workflow for sequencing projects, including sample preparation guidelines, efficient sequencing execution, and comprehensive data analysis methods.
What makes Eurofins Genomics stand out from other sequencing providers?
Eurofins Genomics distinguishes itself through nationwide overnight sequencing, free shipping on most orders, and a wider range of prepaid sequencing options compared to competitors. Their strategic location near UPS headquarters provides unparalleled logistical benefits, allowing for later sample submission times and consistent overnight results from anywhere in the US.
How does Eurofins Genomics stay up-to-date with sequencing technology?
Eurofins Genomics continually updates its sequencing platforms to incorporate the latest technological advancements. They have recently introduced Nanopore sequencing for fast and affordable sequencing of whole plasmids, linear/amplicons, and bacterial genomes. Improvements in data processing and analysis methods have also enhanced the speed and accuracy of results delivery.
